01 163GILEAD SCIENCES INC
01 210086011*PED
02 67964580
03 68334270
04 68575135
05 68580765
06 68618076
07 68633309
08 68735372
09 68889159
10 68921341
11 68940718
12 28957046
13 69085573
14 69284342
15 19296782
16 29757406
17 19868745
18 210086011
19 110912814
20 611116783
21 511116783*PED
22 211338007
23 111338007*PED
24 211707479
25 211707479*PED
26 57964580*PED
27 58334270*PED
28 58575135*PED
29 58580765*PED
30 58618076*PED
31 58633309*PED
32 58735372*PED
33 58889159*PED
34 58921341*PED
35 58940718*PED
36 59085573*PED
37 59284342*PED
38 29757406*PED
01 66Y
02 97Blank
01 83Y
02 80Blank
01 262028-03-21
02 202028-09-21
03 182029-03-26
04 152029-09-26
05 62030-09-13
06 62030-12-11
07 52031-03-13
08 52031-06-11
09 192032-11-16
10 152033-05-16
11 122034-01-30
12 12034-07-17
13 112034-07-30
14 32037-06-01
15 12037-12-01
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8940718
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8575135
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8575135
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2028-03-21
US Patent Number : 8735372
Drug Substance Claim :
Drug Product Claim :
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2034-01-30
US Patent Number : 10086011
Drug Substance Claim :
Drug Product Claim :
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2034-01-30
Patent Expiration Date : 2029-03-26
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 7964580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-26
Patent Expiration Date : 2029-03-26
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 7964580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-26
LOOKING FOR A SUPPLIER?
